HIGHLIGHTS
- who: Antonia De Socio and colleagues from the Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise, Campobasso, Italy have published the research work: Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study, in the Journal: Journal of Immunology Research of 24/01/2018
- what: The aim of this study was to evaluate the serum levels of sclerostin in patients with AS as a possible biomarker and to investigate any correlations with radiographic damage disease activity and function. For all the patients enrolled in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.